Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bouffet

Showing results (461-470 of 471) with videos related to

Pageof 48
Sort By:
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing SurveillanceCarol Durno, Ayse Bahar Ercan, Vanessa Bianchi, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
Nature Communications|March 20, 2021
The transcriptional landscape of Shh medulloblastomaPatryk Skowron, Hamza Farooq, Florence M G Cavalli, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Thomas Hielscher, Stephen C Mack, et al.
The Lancet. Oncology|March 29, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 48

Showing results (461-470 of 471) with videos related to

Sort By:
Pageof 48
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing SurveillanceCarol Durno, Ayse Bahar Ercan, Vanessa Bianchi, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
Nature Communications|March 20, 2021
The transcriptional landscape of Shh medulloblastomaPatryk Skowron, Hamza Farooq, Florence M G Cavalli, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Thomas Hielscher, Stephen C Mack, et al.
The Lancet. Oncology|March 29, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 48